Ipca Labs

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE571A01038
  • NSEID: IPCALAB
  • BSEID: 524494
INR
1,563.70
19.75 (1.28%)
BSENSE

May 06

BSE+NSE Vol: 2.94 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 950228,
    "name": "Ipca Labs",
    "stock_name": "Ipca Labs",
    "full_name": "Ipca Laboratories Ltd",
    "name_url": "stocks-analysis/ipca-labs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,563.70",
    "chg": 19.75,
    "chgp": "1.28%",
    "dir": 1,
    "prev_price": "1,543.95",
    "mcapval": "39,393.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": "524494",
    "symbol": "IPCALAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE571A01038",
    "curr_date": "May 06",
    "curr_time": "",
    "bse_nse_vol": "2.94 lacs",
    "exc_status": "Active",
    "traded_date": "May 06, 2026",
    "traded_date_str": "2026 05 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ipca-labs-950228-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Ipca Laboratories Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ipca-laboratories-ltd-is-rated-hold-3975723",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IpcaLaboratorie_mojoScore_3975723.png",
        "date": "2026-05-05 10:10:34",
        "description": "Ipca Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Ipca Laboratories Gains 6.14%: 2 Key Factors Driving This Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-gains-614-2-key-factors-driving-this-weeks-momentum-3962491",
        "imagepath": "",
        "date": "2026-04-25 14:02:26",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Apr 20:</strong> Stock opens at Rs.1,468.50 with marginal gain</p>\n                    <p><strong>Apr 22:</strong> Technical momentum shifts amid mixed indicator signals</p>\n                    <p><strong>Apr 22:</strong> Valuation shifts signal changing market sentiment</p>\n                    <p><strong>Apr 24:</strong> Stock closes at Rs.1,558.15, up 2.31% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,468.00</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,558.15..."
      },
      {
        "title": "Ipca Laboratories Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ipca-laboratories-ltd-is-rated-hold-3960599",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IpcaLaboratorie_mojoScore_3960599.png",
        "date": "2026-04-24 10:10:31",
        "description": "Ipca Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Ipca Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3957087",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IpcaLaboratorie_technicaldot_3957087.png",
        "date": "2026-04-22 08:03:52",
        "description": "Ipca Laboratories Ltd has exhibited a subtle shift in price momentum, transitioning from a sideways trend to a mildly bullish stance, as reflected in recent technical indicators. Despite mixed signals from key oscillators and moving averages, the stock’s performance relative to the Sensex and its own historical returns offers a nuanced outlook for investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Ipca Laboratories Ltd Valuation Shifts Signal Changing Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-valuation-shifts-signal-changing-market-sentiment-3956800",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IpcaLaboratorie_valuationdot_3956800.png",
        "date": "2026-04-22 08:01:26",
        "description": "Ipca Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, prompting a downgrade in its Mojo Grade from Buy to Hold as of 1 April 2026. With its price-to-earnings (P/E) ratio rising to 36.07 and price-to-book value (P/BV) at 5.06, the stock now trades in the 'expensive' category relative to its historical averages and peer group, signalling a more cautious stance for investors."
      },
      {
        "title": "Ipca Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-technical-momentum-shifts-amid-mixed-market-signals-3950107",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IpcaLaboratorie_technicaldot_3950107.png",
        "date": "2026-04-17 08:03:20",
        "description": "Ipca Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, and moving averages, reflecting a cautious market sentiment despite the company’s resilient long-term performance."
      },
      {
        "title": "Ipca Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3948345",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IpcaLaboratorie_technicaldot_3948345.png",
        "date": "2026-04-16 08:06:11",
        "description": "Ipca Laboratories Ltd has exhibited a subtle but noteworthy shift in its technical momentum, moving from a mildly bearish stance to a mildly bullish one. This transition is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, suggesting a cautiously optimistic outlook for the mid-cap pharmaceutical player amid a volatile market backdrop."
      },
      {
        "title": "Ipca Laboratories Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-ltd-technical-momentum-shifts-amid-mixed-market-signals-3946700",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IpcaLaboratorie_technicaldot_3946700.png",
        "date": "2026-04-15 08:04:18",
        "description": "Ipca Laboratories Ltd has experienced a subtle shift in its technical momentum, moving from a sideways trend to a mildly bearish stance, reflecting a nuanced change in investor sentiment. Despite a slight dip in price, the stock’s technical indicators present a complex picture, with some signals pointing to caution while others suggest underlying resilience."
      },
      {
        "title": "Ipca Laboratories Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ipca-laboratories-ltd-is-rated-hold-by-marketsmojo-3944722",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IpcaLaboratorie_mojoScore_3944722.png",
        "date": "2026-04-13 10:10:03",
        "description": "Ipca Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 April 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 13 April 2026, providing investors with an up-to-date analysis of the company’s performance and outlook."
      }
    ],
    "total": 950,
    "sid": "950228",
    "stock_news_url": "https://www.marketsmojo.com/news/ipca-laboratories-950228"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Standalone And Consolidated Financial Results For 4Th Quarter And Financial Year Ended 31St March 2026 And Dividend",
      "datetime": "04-May-2026",
      "details": "Ipca Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Standalone and Consolidated Financial Results for 4th quarter and financial year ended 31st March 2026 and Dividend",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "08-Apr-2026",
      "details": "The Company has enclosing herewith certificate received from RTA under reg 74 (5) of DP Regulations for the quarter ended 31.03.2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "02-Apr-2026",
      "details": "Newspaper Notice issued by the Company regarding transfer of physical shares.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "29 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Ipca Laboratories Ltd has declared <strong>200%</strong> dividend, ex-date: 05 Aug 25",
          "dt": "2025-08-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Ipca Laboratories Ltd has announced <strong>1:2</strong> stock split, ex-date: 10 Jan 22",
          "dt": "2022-01-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Ipca Laboratories Gains 6.14%: 2 Key Factors Driving This Week’s Momentum

2026-04-25 14:02:26

Key Events This Week

Apr 20: Stock opens at Rs.1,468.50 with marginal gain

Apr 22: Technical momentum shifts amid mixed indicator signals

Apr 22: Valuation shifts signal changing market sentiment

Apr 24: Stock closes at Rs.1,558.15, up 2.31% on the day

stock-recommendationAnnouncement

Board Meeting Intimation for Standalone And Consolidated Financial Results For 4Th Quarter And Financial Year Ended 31St March 2026 And Dividend

04-May-2026 | Source : BSE

Ipca Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Standalone and Consolidated Financial Results for 4th quarter and financial year ended 31st March 2026 and Dividend

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

08-Apr-2026 | Source : BSE

The Company has enclosing herewith certificate received from RTA under reg 74 (5) of DP Regulations for the quarter ended 31.03.2026.

Announcement under Regulation 30 (LODR)-Newspaper Publication

02-Apr-2026 | Source : BSE

Newspaper Notice issued by the Company regarding transfer of physical shares.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

29 May 2026

stock-summary
DIVIDEND

Ipca Laboratories Ltd has declared 200% dividend, ex-date: 05 Aug 25

stock-summary
SPLITS

Ipca Laboratories Ltd has announced 1:2 stock split, ex-date: 10 Jan 22

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available